LimFlow is poised to help patients with severe peripheral artery disease
A French company is developing a therapy that will restore blood flow to the lower leg of patients who have virtually no circulation.
A French company is developing a therapy that will restore blood flow to the lower leg of patients who have virtually no circulation.
Approximately 6.5 million Americans are affected by advanced non-healing wounds each year.